🇺🇸 dexmedetomidine infusion group in United States

dexmedetomidine infusion group (dexmedetomidine infusion group) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

dexmedetomidine infusion group in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is dexmedetomidine infusion group approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for dexmedetomidine infusion group in United States?

Yeungnam University College of Medicine is the originator. The local marketing authorisation holder may differ — check the official source linked above.